Insider buying last 90 days
No open-market insider purchases were filed for NHC in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every NHC insider filing, plotted on the chart in Gekko.Open NHC in Gekko
NYSE Arca: NHC
National HealthCare (NHC) Stock Analysis & Forecast
Oct 12 close
$229.88+2.77 (+1.2%)
Gekko Brief
AI summaryOct 12 closeNational HealthCare recently broke above its 200-day moving average, trading as high as $231.94 and last near $228.27, with quarterly EPS of $1.74 reported on $408.03 million in revenue alongside a declared $0.67 quarterly dividend. The move keeps the stock in focus within the hospital and nursing management space, with no deal, guidance or regulatory news behind the latest activity beyond the moving-average milestone.
NHC last closed at $229.88, up 1.2%, sitting above both its 50-day ($224.00) and 200-day ($187.39) averages, with the 50-day above the 200-day. The stock's one-year return stands at 93.4%, and the 52-week range runs from $116.42 to $239.29. The GekkoIndex reads 55.4, placing NHC in the Neutral zone, while the price sits 30.5% above the Gekko Fair Value of $176.17.
Earnings are due 6 November 2026, 24 days out, falling inside a typical 20-trading-day holding window; the prior report on 6 August 2026 saw a -2.7% reaction, with an average absolute move of 5% historically. Seasonality over the past 5 years shows the next 20 trading days averaging +4.5%, with gains in 4 of those years. No insider, Congress or unusual options activity appears in the current window, leaving smart-money positioning without a clear signal heading into the earnings date.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
National HealthCare price vs fair value
Close $229.88200-day averageGekko Fair Value $176.17
National HealthCare quick facts
- Market cap
- $3.59B
- P/E ratio
- 25.3
- Forward P/E
- 9.9
- EPS, TTM
- $8.89
- Revenue, TTM
- $1.56B
- Profit margin
- 9%
- Dividend yield
- 1.17%
- Beta
- 0.61
- Volume
- 65,274 avg 108,009
- 1-year return
- +93.4%
- Typical daily move
- ±2.7%
- Typical 20-day move
- ±4.1%
- 50-day average
- $224.00
- 200-day average
- $187.39
- Next earnings
- Nov 6
- Shares outstanding
- 15.66M
National HealthCare swing-trade checklist
National HealthCare scores 2 supportive, 1 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive1 mixed2 headwinds
- Trendsupportive
Above 50 and 200-day
Close $229.88 is above the 50-day ($224.00) and 200-day ($187.39) averages, and the 50-day is above the 200-day.
See the chart - GekkoIndexmixed
55.4, Neutral
Reading 55.4 is in the Neutral zone.
See the GekkoIndex - Fair valueheadwind
30.5% above
Price is 30.5% above Gekko Fair Value (more than 5% above).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings riskheadwind
Reports in 25 days
Reports on Nov 6, 2026, 25 days away — inside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+4.5% on average
From this point in the calendar, the next 20 trading days averaged +4.5% over 5 years, rising in 4 of them.
See seasonality
A description of current data, not a recommendation. How this page works
National HealthCare stock chart and price history
National HealthCare closed at $229.88 on Oct 12, 2026, +93.4% over the past year, inside a 52-week range of $116.42 to $239.29.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +2.4%
- 3 months
- +9.1%
- 6 months
- +35.5%
- 1 year
- +93.4%
The full NHC chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open NHC in Gekko
Follow National HealthCare through every session
Put NHC on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track NHC in GekkoFree for 7 days. No credit card required.
National HealthCare GekkoIndex: the smart money zone
National HealthCare’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 55.4, in the Neutral zone, up 1.2 points over five sessions.
55.4Neutral
Up 1.2 points over five sessions.
Reading for Oct 12, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 36 | −1.1% | −0.4% | ||
| Accumulation | 162 | +0.7% | +1.9% | ||
| Neutral (current zone) | 430 | +1.0% | +3.9% | ||
| Distribution | 53 | −0.5% | +1.6% | ||
| Selling | 1 | Too few readings yet | |||
Average NHC share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the NHC price, zone by zone.Track NHC in Gekko
Is National HealthCare stock overvalued? Gekko Fair Value
National HealthCare trades 30.5% above Gekko Fair Value of $176.17, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what National HealthCare shares are worth, recalculated every trading day.
$176.17
Gekko Fair Value, Oct 10, 2026
30.5% Overvalued
At the end of Aug 2026 the price was 16.5% above the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open NHC in Gekko
National HealthCare insider and Congress trading
No open-market insider purchases were filed for National HealthCare, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in NHC were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for NHC, plotted on the chart in Gekko.Open NHC in Gekko
Buybacks
National HealthCare has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $7.24M
- As a share of market cap
- 0.20%
- Trailing four quarters
- $31.91M
From company filings.
National HealthCare earnings: next date and track record
National HealthCare reports on Nov 6, 2026 (25 days away).
Next earnings report
Nov 6, 2026
25 days away
±5%average move across the report
7 of 8reports followed by a gain
Share-price move across each report
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 6, 2026 | $2.54 | $408.0M | −2.7% |
| May 8, 2026 | $2.27 | $380.0M | +10.7% |
| Feb 26, 2026 | $1.58 | $386.5M | +2.0% |
| Nov 7, 2025 | $2.51 | $382.7M | +4.6% |
| Aug 8, 2025 | $1.52 | $373.1M | +7.3% |
| May 9, 2025 | $2.07 | $373.7M | +7.9% |
| Feb 27, 2025 | $0.39 | $369.4M | +0.6% |
| Nov 8, 2024 | $2.73 | $340.2M | +4.5% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
National HealthCare stock forecast and analyst price targets
Analysts’ average 12-month price target for National HealthCare is $6.15, −97.3% from the last close.
$6.15consensus 12-month target, −97.3% from the last close
+3.9%average 20-day move after past Neutral readings
+4.5%average move over the next 20 trading days in the last 5 years
±2.7%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
National HealthCare seasonality: the next 20 trading days
Over the next 20 trading days from Oct 10, National HealthCare averaged +4.5% across the last 5 years, rising in 4 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.9% | 3 of 5 |
| Next 10 trading days | −0.3% | 2 of 5 |
| Next 15 trading days | +0.2% | 2 of 5 |
| Next 20 trading days | +4.5% | 4 of 5 |
| Next 30 trading days | +6.3% | 5 of 5 |
For scale, NHC’s typical 20-trading-day move in either direction is about 4.1%.
National HealthCare market cap and key statistics
National HealthCare’s market cap is $3.59B, with a P/E ratio of 25.3 and revenue of $1.56B over the last twelve months.
Valuation
- Market cap
- $3.59B
- P/E ratio
- 25.3
- Forward P/E
- 9.9
- EPS, TTM
- $8.89
- Gekko Fair Value
- $176.17
Trading
- Volume
- 65,274
- Avg volume, 20 days
- 108,009
- 52-week high
- $239.29
- 52-week low
- $116.42
- Shares outstanding
- 15.66M
Financials
- Revenue, TTM
- $1.56B
- Profit margin
- 9%
- Return on equity
- 13.3%
- Quarterly earnings growth, YoY
- +67.1%
Risk and income
- Beta
- 0.61
- Typical daily move
- ±2.7%
- Typical 20-day move
- ±4.1%
- Dividend yield
- 1.17%
National HealthCare stock news this week
3 headlines about National HealthCare from the past week, newest first, each linking to the publisher.
National HealthCare peers
National HealthCare’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| HCAHCA Healthcare | Neutral | 18.9% above |
| THCTenet Healthcare | Neutral | 6.7% below |
| UHSUniversal Health Services | Neutral | 21.4% below |
| PACSPACS | Neutral | 11.0% below |
| CHEChemed | Accumulation | 7.7% below |
| BKDBrookdale Senior Living | Buying | 22.6% below |
A peer links to its own page where one exists.
National HealthCare stock FAQ
What is National HealthCare’s market cap?
National HealthCare’s market cap is $3.59B at the Oct 12, 2026 close of $229.88, with 15.66M shares outstanding. The shares trade on a P/E ratio of 25.3.
What is the National HealthCare stock forecast?
The consensus analyst 12-month price target for National HealthCare is $6.15, −97.3% from the last close. Gekko doesn’t publish price predictions of its own.
Is National HealthCare stock overvalued or undervalued?
On Gekko’s estimate National HealthCare is overvalued: the Oct 12, 2026 close of $229.88 is 30.5% above Gekko Fair Value of $176.17. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does National HealthCare report earnings next?
National HealthCare is expected to report on Nov 6, 2026 (25 days away).
What is National HealthCare’s 52-week high and low?
National HealthCare’s 52-week high is $239.29 and its 52-week low is $116.42; it closed at $229.88 on Oct 12, 2026, +93.4% over the past year.
Is National HealthCare stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (trend and seasonality), 1 as mixed (gekkoindex) and 2 as headwinds (fair value and earnings risk). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See National HealthCare the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.